InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,650.00
(
0.05%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
0.00%
)
Bitcoin
60,764.25
(
-0.05%
)
Post# of 36
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

braden

Send PM Follow Ignore
Followers 22
Posts 6915
Boards Moderated 0
Alias Born 07/31/2006

braden

Re: None

Sunday, 12/06/2009 10:02:36 AM

Sunday, December 06, 2009 10:02:36 AM

Post# of 36
Pixatrone Phase III Results to be Announced TODAY:

New Pixantrone Phase III Data to be Presented at the 51st Annual Meeting of the American Society of Hematology

SEATTLE , Dec. 2 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that Ruth Pettengell , M.D. of St. George's Hospital , University of London , the lead investigator for the PIX 301 EXTEND trial will present new data on the pixantrone phase III trial in relapsed/refractory aggressive non-Hodgkin's lymphoma (NHL) at the 51st Annual Meeting of the American Society of Hematology on Saturday, December 5, 2009 in New Orleans, Louisiana .

Day trader ideas here.....http://investorshub.advfn.com/boards/board.aspx?board_id=16612

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up